A PHASE-I CLINICAL-TRIAL WITH ONYX-015 (A SELECTIVELY REPLICATING ADENOVIRUS) ADMINISTERED BY INTRATUMORAL INJECTION IN PATIENTS WITH RECURRENT HEAD AND NECK-CARCINOMA

KIRN D GANLEY I NEMUNAITIS J OTTO R SOUTAR D KUHN J HEISE C PROPST M MAACK C ECKHARDT G KAYE S VONHOFF D

D. Kirn et al., A PHASE-I CLINICAL-TRIAL WITH ONYX-015 (A SELECTIVELY REPLICATING ADENOVIRUS) ADMINISTERED BY INTRATUMORAL INJECTION IN PATIENTS WITH RECURRENT HEAD AND NECK-CARCINOMA, Cancer gene therapy, 4(6), 1997, pp. 5-5

NO

Cancer gene therapy → ACNP

09291903

4

6

1997

S

5 - 5

ISI

0929-1903(1997)4:6<5:APCWO(>2.0.ZU;2-R